Our 3rd annual
Wearable Injectors and Connected Devices Conference will explore on-body device design and development whilst also engaging in the latest advances in connectivity and digital health applications for wearable devices with industry perspectives from big pharma representatives. The conference will consider key developments in the
wearable injectors field, including the enhanced demand for on-body injectors and digitalised health as the need for at home self-administration and routes for delivery of time-dependent, high volume and viscous drugs grow.
The conference will also cover key regulatory updates such as guidance on MDR requirements from regulatory and notified bodies, and the importance of considering user-experience and developing patient-centric devices. The two-day conference will bring you high-quality insights and industry connections on the latest advances in
wearable injectors and connectivity, and a platform for exchanging ideas.
Benefits of Attending
- Engage with key regulatory updates surrounding digital health and medical devices
- Discover advances in device design and development for large volume delivery via on-body injectors
- Explore the key drivers of the industry, including the growing development of highly viscous drugs accelerating the development of on-body injectors
- Hear insights into the growing potential of digital health to improve patient experience and treatment
- Engage in design strategy approaches for connected drug delivery devices
Who Should Attend
Executives, Directors, VPs, Heads, Principals, Managers of:
- Drug-Delivery Developers
- Autoinjectors
- Device Engineering
- Human Factors
- Injectables
- Packaging
- Regulatory Affairs
- Connectivity
- Medical Device Data
- Novel Product Technology
- Smart Device Developers
- Device Safety Solution Providers
or anyone who works with Wearable Devices/ On-Body Injectors within pharmaceuticals, biotech, device developers and solution providers.
Plus One Interactive Half-Day Post-Conference Workshops | Wednesday 12th October 2022
Key Challenges and Future Needs for a Successful Product for Targeted PatientsWorkshop Leader: Xavier Donnette, Senior Consultant
13.00 - 17.00
Speakers
- Alex Turner, Electronics and Software Engineer, Crux Product Design Ltd
- Amber Witteman, Founding Director, EPIWatch
- Anne Whalen, Director, Novartis
- Arabe Ahmed, Medicinal Technical Specialist, BSI
- Benjamin Werner, Primary Packaging and Process Development Specialist, Boehringer Ingelheim Pharma GmbH & Co. KG
- Bjorg Kaae Hunter, Department Manager, RA CMC & Device RA Next/Gen Drug-Device, Novo Nordisk
- Blaine Martin, Director, Medical Device Customer Success & Training, Merck KGaA
- Cedric Gysel, Health Care Solutions Manager, Johnson & Johnson
- Claudia Dollins, Head, Global Regulatory Sciences, Precision Medicine, Bristol Myers Squibb
- Geraint Davies, Principal Human Factors Engineer, Roche
- Harminder Mudhar, Associate Director, AstraZeneca
- Ina Rianasari, Laboratory Head, Boehringer Ingelheim Pharma GmbH & Co. KG
- Jan Schuhholz, Scientist, Boehringer Ingelheim Pharma GmbH & Co.KG
- Ling Zheng, Associate Director, Alexion Pharmaceuticals Inc
- Marcus Jarman-Smith, Strategic Marketing Manager and New Business Development, Victrex Plc
- Min Wei, Senior Director, AstraZeneca
- Rachel An, Medical Device Manager, Quantex Arc Ltd
- Samir Shah, Director, AstraZeneca
- Soeren Skov, Senior Human Factors / User experience Engineer, Novartis
- Tom Oakley, Director, Springboard
- Xavier Donnette, Senior Consultant, Freelance
Please fill in your name and email to receive the Conference Agenda of this event.
Venue
Hilton London Kensington
179-199 Holland Park Ave, Kensington, W11 4UL
London, UK
